Aminoglycoside resistance in enterococci isolated from paediatric septicaemia in a tertiary care hospital in north India

Indian Journal of Medical Research, Supplement

Volumn 119, Issue MAY, 2004, Pages 77-79

  Randhawa, V S ^b   Kapoor, L ^b   Singh, V ^a   Mehta, G ^b  

^a Department of Pediatrics   (India)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Enterococci; High level aminoglycoside resistance; Tertiary care hospital

Indexed keywords

AGAR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; GENTAMICIN; STREPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; CHILD; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG USE; ENTEROCOCCUS; HUMAN; INDIA; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NONHUMAN; PEDIATRIC HOSPITAL; SCREENING TEST; SEPTICEMIA; STANDARD;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; HUMANS; INDIA; INFANT, NEWBORN; SEPSIS;

EID: 3442894445     PISSN: 03679012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Patterson JE, Zerros MJ. High-level gentamicin resistance in Enterococcus: Microbiology, genetic basis, and epidemiology. Rev Infect Dis 1990; 12: 644-52.
2. Facklam RR, Teixeira LM. Enterococcus. In: Collier L, Balows A, Sussman M, editors. Topley & Wilson's microbiology and microbial infections. London: Arnold; 1998 p. 669-82.
3. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. Ann Intern Med 1987; 106: 687-91.
4. Herman DJ, Gerding DN. Screening and treatment of infection caused by resistant Enterococi. Antimicrob Agents Chemother 1991; 35: 215-9.
5. Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V, editor. Antibiotics in laboratory medicine. Maryland: William and Wilkins; 1996 p. 330-96.
6. Combes T, Carlier C, Courvalin P. Aminoglycoside-modifying enzyme content of multiple-resistant strains of Streptococcus faecalis. J Antimicrob Chemother 1983; 11: 41-7.
7. Facklam RR, Sahm DF. Enterococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington DC: ASM Press; 1995 p. 308-14.
8. Woods GL, Washington JA. Antibacterial susceptibility tests: Dilution & disc diffusion. In: Murrary PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington DC: ASM Press; 1995 p. 1327-42.
9. Performance standards for antimicrobial susceptibility testing. Eighth informational supplement M100-58, vol. 18. No. 1, 1998, National Committee for Clinical Laboratory Standards, Pennsylvania, USA.
10. Schouten MA, Voss A, Hoogkamp- Korstanje JAA, and the European VRE study group. Antimicrobial susceptibility patterns of Enterococci causing infections of Europe. Antimicrob Agents Chemother 1999; 43: 2542-6.
11. Agarwal VA, Jain YI, Pathak AA. Concomitant high level resistance to penicillin and aminoglycosides in Enterococci at Nagpur, Central India. Indian J Med Microbiol 1999; 17: 85-7.
12. Mundy LM, Sahm DF, Gilmore M. Relationship between Enterococal virulence and antimicrobial resistance. Clin Microbiol Rev 2000; 13: 513-22.